Oxidative stress and mitochondrial dysfunction in neurodegenerative diseases

被引:342
作者
Trushina, E.
McMurray, C. T.
机构
[1] Mayo Clin & Mayo Fdn, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN 55905 USA
[2] Mayo Clin & Mayo Fdn, Dept Biochem & Mol Biol, Rochester, MN 55905 USA
[3] Mayo Clin & Mayo Fdn, Mol Neurosci Program, Rochester, MN 55905 USA
关键词
neurodegeneration; mitochondria; oxidative damage; Huntington's disease; Friedreich ataxia; xeroderma pigmentosum;
D O I
10.1016/j.neuroscience.2006.10.056
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
In recent years, it has become increasingly clear that mitochondrial dysfunction and oxidative damage are major contributors to neuronal loss. Free radicals, typically generated from mitochondrial respiration, cause oxidative damage of nucleic acids, lipids, carbohydrates and proteins. Despite enormous amount of effort, however, the mechanism by which oxidative damage causes neuronal death is not well understood. Emerging data from a number of neurodegenerative diseases suggest that there may be common features of toxicity that are related to oxidative damage. In this review, while focusing on Huntington's disease (HD), we discuss similarities among HD, Friedreich ataxia and xeroderma pigmentosum, which provide insight into shared mechanisms of neuronal death. (C) 2006 Published by Elsevier Ltd on behalf of IBRO.
引用
收藏
页码:1233 / 1248
页数:16
相关论文
共 175 条
  • [1] Iron-dependent self assembly of recombinant yeast frataxin: Implications for Friedreich ataxia
    Adamec, J
    Rusnak, F
    Owen, WG
    Naylor, S
    Benson, LM
    Gacy, AM
    Isaya, G
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 67 (03) : 549 - 562
  • [2] Chelatases: distort to select?
    Al-Karadaghi, S
    Franco, R
    Hansson, M
    Shelnutt, JA
    Isaya, G
    Ferreira, GC
    [J]. TRENDS IN BIOCHEMICAL SCIENCES, 2006, 31 (03) : 135 - 142
  • [3] Creatine increases survival and delays motor symptoms in a transgenic animal model of Huntington's disease
    Andreassen, OA
    Dedeoglu, A
    Ferrante, RJ
    Jenkins, BG
    Ferrante, KL
    Thomas, M
    Friedlich, A
    Browne, SE
    Schilling, G
    Borchelt, DR
    Hersch, SM
    Ross, CA
    Beal, MF
    [J]. NEUROBIOLOGY OF DISEASE, 2001, 8 (03) : 479 - 491
  • [4] Complex I defect in muscle from patients with Huntington's disease
    Arenas, J
    Campos, Y
    Ribacoba, R
    Martín, MA
    Rubio, JC
    Ablanedo, P
    Cabello, A
    [J]. ANNALS OF NEUROLOGY, 1998, 43 (03) : 397 - 400
  • [5] p53 mediates cellular dysfunction and behavioral abnormalities in Huntington's disease
    Bae, BI
    Xu, H
    Igarashi, S
    Fujimuro, M
    Agrawal, N
    Taya, Y
    Hayward, SD
    Moran, TH
    Montell, C
    Ross, CA
    Snyder, SH
    Sawa, A
    [J]. NEURON, 2005, 47 (01) : 29 - 41
  • [6] BEAL MF, 1991, J NEUROSCI, V11, P1649
  • [7] DOES IMPAIRMENT OF ENERGY-METABOLISM RESULT IN EXCITOTOXIC NEURONAL DEATH IN NEURODEGENERATIVE ILLNESSES
    BEAL, MF
    [J]. ANNALS OF NEUROLOGY, 1992, 31 (02) : 119 - 130
  • [8] Mitochondria take center stage in aging and neurodegeneration
    Beal, MF
    [J]. ANNALS OF NEUROLOGY, 2005, 58 (04) : 495 - 505
  • [9] Involvement of mitochondrial complex II defects in neuronal death produced by N-terminus fragment of mutated Huntingtin
    Benchoua, A
    Trioulier, Y
    Zala, D
    Gaillard, MC
    Lefort, N
    Dufour, N
    Saudou, F
    Elalouf, JM
    Hirsch, E
    Hantraye, P
    Déglon, N
    Brouillet, E
    [J]. MOLECULAR BIOLOGY OF THE CELL, 2006, 17 (04) : 1652 - 1663
  • [10] Deranged neuronal calcium signaling and Huntington disease
    Bezprozvanny, I
    Hayden, MR
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 322 (04) : 1310 - 1317